New York Times Draws Attention to Clinical Laboratory Charging $2,315 for a Single COVID-19 Test | Dark Daily
Recent media reports of massive disparities in the prices charged for COVID-19 lab teststhroughout the United States have citizens and law makers alike again calling for increased transparency in clinical laboratory test charges.
One recent example involves the New York Times (NYT), which after learning that Austin-based Gibson Diagnostic Labs (GDL) of Irving, Tex., billed a patient $2,315 for one COVID-19 test, questioned the disparity in coronavirus testing charges. The article, titled, "Most Coronavirus Tests Cost About $100. Why Did One Cost $2,315?" brought unwanted attention to the Texas clinical laboratory.
On July 16, the NYT reported that GDL, "has run some of the most expensive coronavirus tests in America." In addition, the paper reported that health insurance companies have paid GDL $2,315 for individual COVID-19 tests, but that in "a couple of cases," the price rose to $6,946. However, that higher amount resulted "when the lab said it mistakenly charged patients three times the base rate."
Comments
Post a Comment